We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
Cap. Flow
+$518M
Cap. Flow %
0.87%
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$68M
2
TFC icon
Truist Financial
TFC
+$55.9M
3
NOW icon
ServiceNow
NOW
+$33.3M
4
UBER icon
Uber
UBER
+$21.4M
5
LVS icon
Las Vegas Sands
LVS
+$15.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$119M
2
STI
SunTrust Banks, Inc.
STI
+$55.9M
3
AAPL icon
Apple
AAPL
+$48.3M
4
TIP icon
iShares TIPS Bond ETF
TIP
+$22M
5
VIAB
Viacom Inc. Class B
VIAB
+$16.4M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Financials 15.53%
3 Healthcare 13.38%
4 Consumer Discretionary 10.07%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTN
2751
Palatin Technologies
PTN
$14.3M
$199K ﹤0.01%
204
-1
-0.5% -$1.01K
SGC icon
2752
Superior Group of Companies
SGC
$218M
$199K ﹤0.01%
14,713
-444
-3% -$6.41K
PRTK
2753
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$198K ﹤0.01%
49,034
+4,616
+10% +$16K
MUFG icon
2754
Mitsubishi UFJ Financial
MUFG
$246B
$197K ﹤0.01%
36,230
+1,912
+6% +$10.1K
EPM icon
2755
Evolution Petroleum
EPM
$127M
$196K ﹤0.01%
35,876
+425
+1% +$2.34K
KALV
2756
DELISTED
KalVista Pharmaceuticals
KALV
$194K ﹤0.01%
10,877
+238
+2% +$3.11K
JAX
2757
DELISTED
J. Alexander's Holdings, Inc.
JAX
$194K ﹤0.01%
20,315
-169
-0.8% -$1.71K
PDLB icon
2758
Ponce Financial Group
PDLB
$500M
$193K ﹤0.01%
18,272
-95
-0.5% -$967
PLSE icon
2759
Pulse Biosciences
PLSE
$2.64B
$193K ﹤0.01%
14,397
+68
+0.5% +$969
ATHX
2760
DELISTED
Athersys, Inc. Common Stock
ATHX
$192K ﹤0.01%
6,237
-11
-0.2% -$361
MFG icon
2761
Mizuho Financial
MFG
$126B
$190K ﹤0.01%
61,487
-1,347
-2% -$4.2K
SMFG icon
2762
Sumitomo Mitsui Financial
SMFG
$158B
$190K ﹤0.01%
25,653
-535
-2% -$3.85K
NINE
2763
DELISTED
Nine Energy Service
NINE
$189K ﹤0.01%
24,110
+135
+0.6% +$784
ENZ
2764
DELISTED
Enzo Biochem, Inc.
ENZ
$189K ﹤0.01%
71,744
-261
-0.4% -$780
JYNT icon
2765
The Joint Corp
JYNT
$118M
$188K ﹤0.01%
11,650
+169
+1% +$3.07K
KNSA icon
2766
Kiniksa Pharmaceuticals
KNSA
$5.93B
$187K ﹤0.01%
16,863
+335
+2% +$2.91K
ESTE
2767
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$187K ﹤0.01%
29,578
+36
+0.1% +$169
GWRS icon
2768
Global Water Resources
GWRS
$211M
$186K ﹤0.01%
14,144
+124
+0.9% +$1.56K
FFNW
2769
DELISTED
First Financial Northwest, Inc
FFNW
$186K ﹤0.01%
12,429
+127
+1% +$1.84K
GEN
2770
DELISTED
Genesis Healthcare, Inc.
GEN
$186K ﹤0.01%
113,532
+5,536
+5% +$8.31K
ADMA icon
2771
ADMA Biologics
ADMA
$2.07B
$185K ﹤0.01%
46,364
+523
+1% +$2.28K
CCO icon
2772
Clear Channel Outdoor Holdings
CCO
$1.24B
$185K ﹤0.01%
64,581
+2,446
+4% +$6.19K
RMBI icon
2773
Richmond Mutual Bancorp
RMBI
$253M
$185K ﹤0.01%
11,619
+439
+4% +$6.32K
FTR
2774
DELISTED
Frontier Communications Corp.
FTR
$185K ﹤0.01%
207,364
-155,404
-43% -$127K
TWIN icon
2775
Twin Disc
TWIN
$346M
$182K ﹤0.01%
16,488
-30
-0.2% -$314
109 110
111
112 113

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
  • RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
  • RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
  • RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
  • RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
  • RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.

Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.